At least 12 single nucleotide polymorphisms (SNPs) within the 5Ј upstream regulatory region of the human CCR5 chemokine and HIV-1 receptor gene have been described (1) (2) (3) (4) . Our recent report (1) and others (2) have shown that a common 10-SNP allele haplotype, CCR5P1, with demonstrated promoter activity (5) confers relatively rapid progression to various AIDS end points in a genetic epidemiologic analysis of 2603 patients. Although quantitative differences in expression between CCR5 coding alleles (CCR5-ϩ versus CCR5-⌬32) are apparent (6, 7) , we observed no appreciable constitutive differences among CCR5 promoter alleles (P1 and P4) in HIV-1 binding, in chemokinemediated signal transduction, or in CCR5 quantification (1) .
We have found a distinction in specific binding affinity for separate CCR5P allele sequence motifs to nuclear binding (potential transcription) factors, which suggests a possible mechanism for CCR5P1/P1 epidemiologic consequences. We used electrophoretic mobility-shift analysis (8) (EMSA) to assess DNAprotein interactions with the common CCR5P1 (frequency, f ϭ 0.56) and CCR5P4 ( f ϭ 0.35) alleles. Synthetic allele-specific oligonucleotides (ϳ20 bp), representing polymorphic CCR5P sites 208 (G/T), 627 (C/T), 676 (A/G), and 303 (A/G) (2) in the context of their adjacent nucleotides, were incubated with nuclear extracts from phytohemmaglutinin (PHA)-blasted phorbolmyristate acetate (PMA) and ionomyocin-treated human T cells (8) . Variants at three sites (303, 627, and 676) showed no difference in binding for alternative allele oligonucleotides; however, the T-bearing oligonucleotide at site 208 (carried in CCR5P3 and P4) (1) displayed 5-to 12-fold greater binding to a specific nuclear binding protein (or proteins) than did the G-bearing oligonucleotide ( We examined the sequence surrounding CCR5P site 208 for sequence homology to binding sites for previously described transcription factors (9) . The sequence revealed significant homology to sites capable of binding to cRel (a member of the Rel/NF-B family). We incubated specific antibodies to cRel (10), p50 (11) , and p65 (11) with the 208T oligonucleotide. We then performed EMSAs, and each antibody resolved unique complexes in addition to complex A (Fig. 1, complex C) . The 208G allele also produced a weak supershift complex with the three antisera, which indicates that this sequence is also capable of binding cRel, p50, and p65 (12) . The intensity of the supershift complex (complex C) relative to complex A is similar whether 208G or 208T is tested, and neither allele appreciably diminishes the major allele specific complex A, as measured by supershift experiments that use the Rel/NF-B family antisera. Therefore, it seems the predominant interaction of CCR5P4 (that is, complex A) involves other yet to be identified binding factors in addition to the three implicated transcription factors.
The identification of differential binding (Table 1) . In every case, the CCR5P1/P1 genotypes alone were associated with rapid progression, while the CCR5P2-bearing genotypes did not progress more rapidly than other CCR5P genotypes. For this reason, we conclude that the 208G/T polymorphism differential binding to nuclear factors cannot fully explain the reported epidemiological data (1, 2) . Nevertheless, the presence of a mixture of nuclear binding factors which discriminate among CCR5 promoter alleles remains a viable possibility to account for differential availability of CCR5 receptors in various cell populations. The nuclear factors may vary in abundance among different cell types and respond to diverse stimuli that mediate CCR5 transcription. Defining the implications of these events is an important goal of ongoing experiments.
